Literature DB >> 8618525

World distribution of factor V Leiden.

N Dzimiri, B Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8618525     DOI： 10.1016/s0140-6736(96)90064-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Prothrombotic and atherosclerotic risk factors lack significance in NAION patients harbouring mitochondrial DNA mutations.

Authors:  K K Abu-Amero; T M Bosley
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.

Authors:  Ali A Dashti; Mehrez M Jadaon
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

3.  Prevalence of resistence to activated protein C (APC-resistance) in blood donors in Kosovo.

Authors:  Ymer Mekaj; Bukurije Zhubi; Hakif Hoxha; Remzije Belegu; Agon Mekaj; Ermira Miftari; Mazllum Belegu
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

Review 4.  The role of ethnicity, age and gender in venous thromboembolism.

Authors:  Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

5.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

6.  Prevalence and role of antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy.

Authors:  Ymer Mekaj; Shefqet Lulaj; Fetie Daci; Naser Rafuna; Ermira Miftari; Hakif Hoxha; Xhemile Sllamniku; Agon Mekaj
Journal:  J Hum Reprod Sci       Date:  2015 Oct-Dec

7.  Molecular assessment of some cardiovascular genetic risk factors among Iraqi patients with ischemic heart diseases.

Authors:  Wisam Jasim Mohammed; Bassam Musa Sadik Al-Musawi; Christian Oberkanins; Helene Pühringer
Journal:  Int J Health Sci (Qassim)       Date:  2018 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.